Optimizing cochlear implant settings for better speech understanding
A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes
NA · NYU Langone Health · NCT05219474
This study is testing if using computer models to find the best settings for cochlear implants can help people with hearing loss understand speech better than standard settings.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 45 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | NYU Langone Health (other) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05219474 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance speech understanding in cochlear implant users by utilizing computational models to identify the best combinations of active electrodes. It will compare the effectiveness of model-recommended settings against standard care and two control combinations. The research includes quantifying speech understanding and sound quality, and translating findings into practical guidance for electrode deactivation. The goal is to provide personalized settings that improve communication outcomes for patients with hearing loss.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with unilateral cochlear implants and at least one year of experience.
Not a fit: Patients with other communicative or cognitive disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve speech understanding for cochlear implant users.
How similar studies have performed: While the approach is innovative, similar studies have shown promise in optimizing cochlear implant settings, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Cochlear implant subjects * must be older than the age of 18 * implanted unilaterally with CI with at least 1 year of experience * no diagnosis of any other communicative or cognitive disorder. * English-speaking * willingness and ability to provide informed consent Normal hearing subjects * must be older than age of 18 * no diagnosis of any other communicative or cognitive disorder. * English-speaking * willingness and ability to provide informed consent Exclusion Criteria: not meeting the inclusion criteria above
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Elad Sagi, MD — NYU Langone Health
- Study coordinator: Elad Sagi
- Email: Elad.Sagi@nyulangone.org
- Phone: 212-263-7765
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hearing Loss